Friday 3/28 Insider Buying Report: AKRO
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Today we look at one noteworthy recent insider buy.
On Thursday, Akero Therapeutics', G. Walmsley Graham, made a $8.79M buy of AKRO, purchasing 200,000 shares at a cost of $43.94 a piece. Akero Therapeutics is trading down about 0.7% on the day Friday. Before this latest buy, Graham made one other buy in the past twelve months, purchasing $9.6M shares for a cost of $48.00 each.
VIDEO: Friday 3/28 Insider Buying Report: AKRO
BNK Invest Inc. provides investment services and information. BNK Invest owns and operates a market news family of websites including DividendChannel, ETFChannel, StockOptionsChannel, and others, which make up an investor community featuring stock message boards, ratings, research, and strategies. BNK Invest caters to investing firms and individual investors internationally.